|
1
|
Shackleton M, Quintana E, Fearon ER and
Morrison SJ: Heterogeneity in cancer: Cancer stem cells versus
clonal evolution. Cell. 138:822–829. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McCracken KW, Catá EM, Crawford CM,
Sinagoga KL, Schumacher M, Rockich BE, Tsai YH, Mayhew CN, Spence
JR, Zavros Y, et al: Modelling human development and disease in
pluripotent stem-cell-derived gastric organoids. Nature.
516:400–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao Y, Feng F and Zhou YN: Stem cells in
gastric cancer. World J Gastroenterol. 21:112–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maeda M, Yamashita S, Shimazu T, Iida N,
Takeshima H, Nakajima T, Oda I, Nanjo S, Kusano C, Mori A, et al:
Novel epigenetic markers for gastric cancer risk stratification in
individuals after Helicobacter pylori eradication. Gastric Cancer.
21:745–755. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yaghoobi M, Bijarchi R and Narod SA:
Family history and the risk of gastric cancer. Br J Cancer.
102:237–242. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsuo J, Kimura S, Yamamura A, Koh CP,
Hossain MZ, Heng DL, Kohu K, Voon DC, Hiai H, Unno M, et al:
Identification of stem cells in the epithelium of the stomach
corpus and antrum of mice. Gastroenterology. 152:218–231.e14. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tatsumoto T, Xie X, Blumenthal R, Okamoto
I and Miki T: Human ECT2 is an exchange factor for Rho GTPases,
phosphorylated in G2/M phases, and involved in cytokinesis. J Cell
Biol. 147:921–928. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan AM, McGovern ES, Catalano G, Fleming
TP and Miki T: Expression cDNA cloning of a novel oncogene with
sequence similarity to regulators of small GTP-binding proteins.
Oncogene. 9:1057–1063. 1994.PubMed/NCBI
|
|
10
|
Chen J, Xia H, Zhang X, Karthik S, Pratap
SV, Ooi LL, Hong W and Hui KM: ECT2 regulates the Rho/ERK
signalling axis to promote early recurrence in human hepatocellular
carcinoma. J Hepatol. 62:1287–1295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu B, Yang H, Taher L, Denz A, Grützmann
R, Pilarsky C and Weber GF: Identification of prognostic biomarkers
by combined mRNA and miRNA expression microarray analysis in
pancreatic cancer. Transl Oncol. 11:700–714. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou S, Wang P, Su X, Chen J, Chen H, Yang
H, Fang A, Xie L, Yao Y and Yang J: High ECT2 expression is an
independent prognostic factor for poor overall survival and
recurrence-free survival in non-small cell lung adenocarcinoma.
PLoS One. 12:e01873562017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sano M, Genkai N, Yajima N, Tsuchiya N,
Homma J, Tanaka R, Miki T and Yamanaka R: Expression level of ECT2
proto-oncogene correlates with prognosis in glioma patients. Oncol
Rep. 16:1093–1098. 2006.PubMed/NCBI
|
|
14
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch
CM, Winchester DP, Asare EA, Madera M, Gress DM and Meyer LR: AJCC
Cancer Staging Manual. 8th. Springer; New York, NY: 2016
|
|
15
|
Cho JY, Lim JY, Cheong JH, Park YY, Yoon
SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, et al: Gene expression
signature-based prognostic risk score in gastric cancer. Clin
Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang G, Hu N, Yang HH, Wang L, Su H, Wang
C, Clifford R, Dawsey EM, Li JM, Ding T, et al: Comparison of
global gene expression of gastric cardia and noncardia cancers from
a high-risk population in china. PLoS One. 8:e638262013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SY, Park C, Kim HJ, Park J, Hwang J,
Kim JI, Choi MG, Kim S, Kim KM and Kang MS: Deregulation of immune
response genes in patients with Epstein-Barr virus-associated
gastric cancer and outcomes. Gastroenterology. 148:137–147.e9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li H, Yu B, Li J, Su L, Yan M, Zhang J, Li
C, Zhu Z and Liu B: Characterization of differentially expressed
genes involved in pathways associated with gastric cancer. PLoS
One. 10:e01250132015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han JY, Han YK, Park GY, Kim SD and Lee
CG, Jo WS and Lee CG: Bub1 is required for maintaining cancer stem
cells in breast cancer cell lines. Sci Rep. 5:159932015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Venere M, Miller TE and Rich JN: Mitotic
control of cancer stem cells. Cancer Discov. 3:141–144. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mariani SA, Minieri V, De Dominici M,
Iacobucci I, Peterson LF and Calabretta B: CDKN2A-independent role
of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic
leukemia. Leukemia. 30:1682–1690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hur W and Yoon SK: Molecular pathogenesis
of radiation-induced cell toxicity in stem cells. Int J Mol Sci.
18:27492017. View Article : Google Scholar
|
|
24
|
Moore N and Lyle S: Quiescent,
slow-cycling stem cell populations in cancer: A review of the
evidence and discussion of significance. J Oncol. 2011:3960762011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gjoerup OV, Wu J, Chandler-Militello D,
Williams GL, Zhao J, Schaffhausen B, Jat PS and Roberts TM:
Surveillance mechanism linking Bub1 loss to the p53 pathway. Proc
Natl Acad Sci USA. 104:8334–8339. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu B, Xu T, Liu H, Min Q, Wang S and Song
Q: miR-490-5p suppresses cell proliferation and invasion by
targeting BUB1 in hepatocellular carcinoma cells. Pharmacology.
100:269–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mitxelena J, Apraiz A, Vallejo-Rodríguez
J, Malumbres M and Zubiaga AM: E2F7 regulates transcription and
maturation of multiple microRNAs to restrain cell proliferation.
Nucleic Acids Res. 44:5557–5570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma YS, Lv ZW, Yu F, Chang ZY, Cong XL,
Zhong XM, Lu GX, Zhu J and Fu D: MicroRNA-302a/d inhibits the
self-renewal capability and cell cycle entry of liver cancer stem
cells by targeting the E2F7/AKT axis. J Exp Clin Cancer Res.
37:2522018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pan YQ, Ruan YY, Peng JB, Han QY, Zhang X,
Lin A and Yan WH: Diagnostic significance of soluble human
leukocyte antigen-G for gastric cancer. Hum Immunol. 77:317–324.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Toiyama Y, Okugawa Y and Goel A: DNA
methylation and microRNA biomarkers for noninvasive detection of
gastric and colorectal cancer. Biochem Biophys Res Commun.
455:43–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin Y, Yu Y, Shao Q, Ma Y, Zhang R, Yao H
and Xu Y: Up-regulation of ECT2 is associated with poor prognosis
in gastric cancer patients. Int J Clin Exp Pathol. 7:8724–8731.
2014.PubMed/NCBI
|
|
32
|
Wang HB, Yan HC and Liu Y: Clinical
significance of ECT2 expression in tissue and serum of gastric
cancer patients. Clin Transl Oncol. 18:735–742. 2016. View Article : Google Scholar : PubMed/NCBIPubMed/NCBIPubMed/NCBIPubMed/NCBI
|
